How to Talk to Your Doctor About GLP-1 Therapy

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Bringing up GLP-1 therapy with your physician might feel uncomfortable, but clinical evidence shows glucagon-like peptide-1 receptor agonists reduce body weight by 15-22% on average when combined with lifestyle changes. The conversation opens a door to personalized treatment that addresses your specific metabolic needs and health goals.

Prepare Your Medical History Before the Appointment

Organize a timeline of your weight management efforts over the past five years, including diets attempted, exercise regimens, and any medications tried. Include your family history of obesity, type 2 diabetes, or heart disease—these factors make GLP-1 therapy increasingly relevant to your care. Document your current weight, BMI, blood pressure readings, and any metabolic lab results from the past 12 months.

Bring a list of all supplements and medications you currently take, as GLP-1 compounds interact with certain prescriptions and require dosing adjustments. Note any previous side effects from weight loss medications or other injectable treatments. This background information helps your doctor assess whether GLP-1 therapy fits your medical profile and what safeguards need to be in place.

Explain Your Weight Loss Goals and Motivation

Share specific, measurable goals rather than vague targets—for example, 'I want to lose 30 pounds in six months to improve my knee pain and reduce my diabetes medications.' Describe how your current weight affects your daily life: mobility limitations, energy levels, sleep quality, or emotional wellbeing. Doctors respond more openly when patients articulate the personal impact, not just the number on the scale.

Be honest about what lifestyle changes you've sustained and where you struggle. If you've successfully maintained exercise but can't control hunger despite dieting, that's valuable clinical information showing appetite regulation may be your limiting factor. GLP-1 therapy works by reshaping hunger signals, making it ideal for this specific challenge.

Present the Clinical Evidence for GLP-1 Effectiveness

Reference landmark trials your doctor will recognize: semaglutide studies demonstrated 14-15% weight loss in non-diabetic populations, while tirzepatide (dual GIP/GLP-1 agonist) showed up to 22% reductions in phase 3 trials. Mention cardiovascular benefits documented in major trials, including reduced heart attack and stroke risk in patients with existing heart disease. Cite real-world data showing improved blood pressure, cholesterol, and inflammation markers even before significant weight loss occurs.

Ask your doctor specifically about semaglutide's mechanism—it slows gastric emptying, increases fullness hormones, and reduces hunger-drive brain activity. This differs fundamentally from older weight loss drugs, making it appropriate for patients who failed previous medications. If you've heard about GLP-1 therapy in media, acknowledge that while focusing on the peer-reviewed evidence that convinced the FDA and insurance companies of its value.

Address Safety Concerns and Realistic Side Effects

Ask your doctor directly: 'What are the most common side effects I should expect, and how long do they typically last?' Nausea and mild gastrointestinal changes are normal in the first 2-4 weeks as your body adjusts; they're not dangerous, but your doctor should confirm manageable strategies like smaller meals and ginger supplements. Inquire about contraindications—GLP-1 therapy isn't suitable for patients with personal or family history of medullary thyroid cancer or MEN2 syndrome, but your doctor can rule these out quickly.

Discuss what 'dose titration' means: your starting dose is low, and increases happen gradually over weeks to months, allowing your body to adapt. This approach minimizes side effects while maintaining efficacy. Ask your doctor to explain monitoring parameters—weight checks, blood pressure, and periodic metabolic labs—so you understand the supervision plan.

Introduce PlexusDx as an Affordable, Accessible Option

If your doctor is open to GLP-1 therapy, explain that PlexusDx offers compounded semaglutide at $189/mo month-to-month, or from $149/mo on the 6-month plan from licensed 503A pharmacies, making treatment accessible without insurance or membership fees. Compounded medications are legally prescribed by your doctor and dispensed by regulated pharmacies—this is a mainstream pathway for thousands of patients. Tell your doctor that PlexusDx compounds are pharmacist-verified for sterility and potency, meeting the same standards as branded alternatives at a fraction of the cost.

Mention that PlexusDx serves all 50 states and accepts HSA/FSA funds, removing financial barriers to consistent treatment. If your doctor has never prescribed through a compounding pharmacy, offer to provide PlexusDx contact information so they can verify credentials and review the ordering process. Many physicians appreciate the straightforward model: one flat monthly price regardless of dose, so 'your dose may need to go up, but your price won't.'

Ask About Genetic Personalization and Testing

Inquire whether your doctor thinks genetic testing might help optimize your GLP-1 therapy. PlexusDx offers the Precision Peptide Genetic Test, which identifies your unique peptide-pathway genetics across 14 metabolic pathways and 49 peptides—revealing how your body responds to GLP-1 compounds based on variants in genes like GIPR. This $298 test (available after one month of treatment) provides insights beyond standard pharmacogenomics, helping your doctor fine-tune dosing and choose between semaglutide, tirzepatide, or combination formulas.

The PlexusDx Precision Peptide Genetic Test analyzes FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to GLP-1 medications or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What if my doctor has never prescribed GLP-1 therapy before?

Many primary care physicians are still ramping up expertise with GLP-1 compounds. Offer to bring educational materials or suggest your doctor consult with an obesity medicine specialist or endocrinologist familiar with these medications.

Should I mention that I want compounded semaglutide specifically?

Yes, but frame it as a cost and access question after your doctor agrees GLP-1 therapy is medically appropriate. Say: 'I've researched PlexusDx compounded semaglutide as an affordable option at $189/mo month-to-month, or from $149/mo on the 6-month plan. Would you be comfortable prescribing through a licensed compounding pharmacy?'

What questions should I ask about how long treatment lasts?

Ask whether GLP-1 therapy is temporary (to lose weight and establish habits) or ongoing (for long-term weight maintenance and metabolic benefits). Clarify what happens if you stop medication—most patients regain some weight, so maintenance dosing is often the plan.

How do I respond if my doctor is skeptical about GLP-1 for non-diabetic weight loss?

Acknowledge his concern respectfully, then share that major trials (STEP 1-4 for semaglutide, SURMOUNT trials for tirzepatide) involved non-diabetic patients and showed robust cardiovascular and metabolic benefits. Offer to send peer-reviewed abstracts from these trials to his email.

Can I ask my doctor about the Precision Peptide Genetic Test at our first visit?

It's better to wait until you've been on treatment for one month—the test is available after your first month of therapy and helps optimize dosing based on your genetic peptide pathways.

Related Reading

• Maximus Glp 1
• Found Glp 1
• Orderly Meds Glp 1
• Henry Meds Glp 1

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.